Friday, September 13
*All times are in Almaty Time (GMT+5).
Various sponsored sessions will take place the day before the meeting for national and regional participants.
09:00 - 09:30 Registration
09:30 - 11:25 Sponsored Presentations
Chairs: Z Gulbash (Türkiye), S Gabbasova (Kazakhstan) & S Sultangaziyeva (Kazakhstan)
|
Prospects for the implementation of optimal approaches in the treatment of DLBCL
Supported by Roche
|
S Gabbasova (Kazakhstan)
|
|
Important aspects of management of patients with DLBCL
Supported by Roche
|
A Jazyltaeva (Kazakhstan)
|
|
APL in 2024: a review of international clinical guidelines and research results
Supported by Medac
|
A Klodzinsky (Kazakhstan)
|
|
Treatment and transplantation in relapsed acute myeloid leukemia
|
Z Gulbash (Türkiye)
|
|
Possibilities of therapy of hematological diseases. The role of Eltrombopagum
Supported by Nobel
|
A Shalabay (Kazakhstan)
|
|
Optimization of the choice of therapy for chronic lymphocytic leukemia
Supported by AbbVie
|
S Gabbasova (Kazakhstan)
|
11:25 - 11:40 Coffee break
Satellite symposium: R-pharm - Immune therapy of Hodgkin lymphoma
Chairs: P Zeynalova (Russia) & V Kemaykin (Kazakhstan)
|
Review of oncohematology service in the Republic of Kazakhstan
|
V Kemaykin (Kazakhstan)
|
|
Immunotherapeutic approaches to the treatment of Hodgkin lymphoma
|
P Zeynalova (Russia)
|
12:25 - 13:25 Satellite Symposium: Janssen - Multiple Myeloma - Diagnosis and Treatment Approaches
Chairs: A Satbaldieva (Kazakhstan)
|
Clinical review of Daratumumab therapy in patients with multiple myeloma
|
A Satbaldieva (Kazakhstan)
|
|
Clinical review of Daratumumab therapy in patients with multiple myeloma
|
B Nassipov (Kazakhstan)
|
|
Clinical review of Daratumumab therapy in patients with multiple myeloma
|
Z Serikbolova (Kazakhstan)
|
13:25 - 14:00 Lunch
14:00 - 15:00 Satellite Symposium: AstraZeneca - Mysteries of oncohematology: What? Where? When?
Chairs: A Klodzinsky (Kazakhstan) & S Gabbasova (Kazakhstan)
|
CLL: From the theory of improbability to reality
|
L Turgunova (Kazakhstan)
|
|
What was the complex pazzle CLL about?
|
L Shukirova (Kazakhstan)
|
|
What will the complex puzzle CLL involve?
|
G Torebayeva (Kazakhstan)
|
|
How to put the puzzle together when choosing CLL therapy
|
A Koshkarbayeva (Kazakhstan)
|
15:00 - 15:45 Satellite Symposium: Novartis - Modern approaches to the treatment of patients with MPN: the role of prognosis and risk factors
Chairs: I Pivovarova (Kazakhstan)
|
Benefits of Early Administration of JAK Inhibitors in Patients with Primary Myelofibrosis
|
M Fominykh (Kazakhstan)
|
| Prospects in treatment approaches of high-risk polycythemia vera |
A Klodzinsky (Kazakhstan)
|
|
Diagnostics of MPN in Kazakhstan, challenges and solutions
|
I Pivovarova (Kazakhstan)
|
15:45 - 16:30 Satellite Symposium: Pfizer - 7+3 no changes 40 years. Time for innovations in AML treatment.
Chairs: S Gabbasova (Kazakhstan)
|
ALFA-0701 Focus on efficiency: double increase in relapse-free survival
|
S Gabbasova (Kazakhstan)
|
|
Gemtuzumab ozogamicin. Safety and adverse events management considerations
|
A Jazyltayeva (Kazakhstan)
|
|
The role of gemtuzumab ozogamicin in international treatment guidelines for AML today
|
N Kemelbekov (Kazakhstan)
|
16:30 - 17:30 Satellite Symposium: Takeda - Possibilities of targeted therapy in 1st line of CD30 positive lymphomas
Chairs: S Gabbasova (Kazakhstan)
|
ECHELON-1 Study 7-Year Analysis
|
S Gabbasova (Kazakhstan)
|
|
Prospects for targeted therapy in advanced stages of Hodgkin lymphoma
|
N Kemelbekov (Kazakhstan)
|
17:30 - 18:30 Satellite Symposium: КPK - New strategies in the treatment of acute B-lymphoblastic leukemia
Chairs: G Sagindykov (Kazakhstan)
|
How to improve treatment outcomes for acute B-lymphoblastic leukemia in adults in Kazakhstan today
|
A Klodzinsky (Kazakhstan)
|
|
Clinical case of a patient with B-ALL
|
G Sagindykov (Kazakhstan)
|
18:30 - 19:00 Opening Ceremony
Chairs: D Kaidarova (Kazakhstan) & M Doubek (Czechia)
19:00 - 22:00 Dinner
Back